After adjusting for competing mortality as well as age, sex, history of bone fractures, BMD and PTH levels, the HR was 0.64 (95% CI, 0.27–1.51), indicating no statistically significant difference between the two groups (Table 2). The gene discussed is PTH; the disease is bone fracture.